Pediatric cellular therapies and transplants are among the most promising advancements in modern medicine, offering hope to children battling life-threatening diseases such as leukemia, thalassemia, and immune disorders. However, ensuring equitable access, high-quality treatment, and better patient outcomes requires an enabling ecosystem that promotes innovation, collaboration, and capacity building. The Society for Pediatric Cellular Therapy and Transplant (SPCTT) is committed to transforming pediatric care in India, and the world.
SPCTT’s primary goal is bridging research, clinical practice, and public health gaps. By facilitating collaboration among clinicians, researchers, pharma companies, and policymakers, SPCTT promotes the development of cutting-edge therapies for pediatric patients. Through workshops, conferences, and training programs, the organisation empowers healthcare providers with knowledge and skills required to deliver effective treatments....
The SPCTT Executive Committee comprises dedicated doctors guiding the society's vision and initiatives. They ensure excellence in advancing pediatric cellular therapy and transplant through strategic planning, collaboration, and impactful decision-making.
President
Secretary
Treasurer
Co-Treasurer
In the dynamic fields of hematology and bone marrow transplantation (BMT), staying updated with the latest advancements is crucial. These specialities are rapidly evolving..
The field of pediatric cellular therapies and bone marrow transplant is advancing rapidly, offering hope to children with severe hematological conditions...
In the ever-evolving fields of pediatric cellular therapies and bone marrow transplant (BMT), staying informed about the latest advancements is crucial for clinicians...
Bone marrow transplant (BMT) has long been a cornerstone of treatment for severe blood disorders such as thalassemia and sickle cell anemia, offering a potential cure for children facing life-threatening conditions
×